![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Simtuzumab, an Antifibrotic Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2) Enzyme, Is Safe and Well Tolerated in Patients With Liver Disease
|
|
|
Reported by Jules Levin
EASL 2013 April Amsterdam
Andrew H. Talal1,2, Marlene Feron-Rigodon1, Jeannine Madere3, Xiaoru Wu3, G. Mani Subramanian3, Jeffrey D. Bornstein3
1Weill-Cornell Medical College, New York, NY, USA; 2SUNY-Buffalo, Buffalo, NY, USA; 3Gilead Sciences, Inc., Foster City, CA, USA
![HIV1.gif](../images/053013/053013-3/HIV1.gif)
![HIV2.gif](../images/053013/053013-3/HIV2.gif)
![HIV3.gif](../images/053013/053013-3/HIV3.gif)
![HIV4.gif](../images/053013/053013-3/HIV4.gif)
![HIV5.gif](../images/053013/053013-3/HIV5.gif)
![HIV6.gif](../images/053013/053013-3/HIV6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|